Winfield Associates’s Enovis ENOV Stock Holding History

Winfield Associates’s Portfolio ENOV Stock Details ENOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-9	Closed	-$1K	–	840
2017 Q3	$1K	Hold	9	–	–	﹤0.01%	679
2017 Q2	$1K	Buy	+9	New	+$614	﹤0.01%	773

Other funds holding ENOV

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BCP

BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Bares Capital Management Austin, Texas $1.08B AUM 38.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Winfield Associates's ENOV Position: Q4 2017 in Review

Winfield Associates sold out of Enovis (ENOV) in Q4 2017, closing a stake of 9 shares — an estimated $1K sold.

Winfield Associates first reported a position in ENOV in Q2 2017 and held it in 2 quarters. The position peaked at $1K in Q3 2017. 210 funds tracked by Wall St. Rank hold ENOV as of Q4 2017.

Winfield Associates reported no remaining Enovis position as of Q4 2017 after selling out during the quarter.
Winfield Associates sold 9 Enovis shares in Q4 2017, an estimated $1K.
Winfield Associates first reported a position in Enovis in Q2 2017 and held it in 2 quarters.
Winfield Associates's Enovis position peaked at $1K in Q3 2017.
210 funds tracked by Wall St. Rank held Enovis as of Q4 2017.

Based on Winfield Associates's 13F filing for Q4 2017, filed 12 Feb 2018.